已收盤 05-01 16:00:00 美东时间
-0.640
-3.91%
Sanuwave Health, Inc. (the "Company" or "Sanuwave") (NASDAQ:SNWV), a leading provider of FDA-approved directed energy systems used in advanced wound care, today announced that revenues for the first quarter of 2026
04-17 05:03
今日重点评级关注:Oppenheimer:维持Alumis"跑赢大市"评级,目标价从50美元升至55美元;美银证券:维持Rocket Pharmaceuticals"买入"评级,目标价从8美元升至9美元
03-31 16:30
Roth Capital analyst Kyle Bauser reiterates SANUWAVE Health (NASDAQ:SNWV) with a Buy and lowers the price target from $53 to $47.
03-31 02:03
SANUWAVE Health (OTC:SNWV) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.14 by 77.78 percent. This is a 102.7 percent increase over losses of $(1.11) per share from the
03-27 04:40
SANUWAVE Health (NASDAQ:SNWV) narrows FY2025 sales outlook from $44.000 million-$45.000 million to $44.300 million-$44.400 million.
01-12 21:46
SANUWAVE Health (NASDAQ:SNWV) narrows Q4 sales outlook from $13.000 million-$14.000 million to $13.300 million-$13.400 million.
01-12 21:45
Healogics Wound Care Supply adds UltraMIST to its Group Purchasing OrganizationHealogics iSupply and Sanuwave collaborate to provide UltraMIST as an option for GPO members
2025-12-08 19:02
SANUWAVE Health (OTC:SNWV) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.32 by 43.75 percent. This is a 107.09 percent increase over losses of $(6.49) per share from the
2025-11-07 05:58
SANUWAVE Health (OTC:SNWV) will release its quarterly earnings report on Thursd...
2025-11-06 04:03